Hancock Jaffe Laboratories Inc ROIC
What is the ROIC of Hancock Jaffe Laboratories Inc?
The ROIC of Hancock Jaffe Laboratories Inc is -130.76%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Hancock Jaffe Laboratories Inc
What does Hancock Jaffe Laboratories Inc do?
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product candidates: the VenoValveÒ, a porcine-based valve which is intended to be surgically implanted in the deep venous system of the leg to treat reflux associated with Chronic Venous Insufficiency, and the CoreoGraftÒ, a bovine tissue-based off-the-shelf conduit intended to be used for coronary artery bypass surgery.
Companies with roic similar to Hancock Jaffe Laboratories Inc
- Alternate Health has ROIC of -131.22%
- Akari Therapeutics Plc has ROIC of -131.14%
- Ideanomics Inc has ROIC of -130.90%
- Claren has ROIC of -130.90%
- KWESST Micro Systems has ROIC of -130.86%
- KWESST Micro Systems has ROIC of -130.86%
- Hancock Jaffe Laboratories Inc has ROIC of -130.76%
- Tetra Bio-Pharma has ROIC of -130.74%
- Odyssey Semiconductor Technologies has ROIC of -130.61%
- G2 Technologies has ROIC of -130.35%
- T2 Biosystems Inc has ROIC of -129.43%
- Allena Pharmaceuticals Inc has ROIC of -129.33%
- Aurum Resources Ltd has ROIC of -128.63%